NeuroVigil’s iBrain: Revolutionizing Brain Monitoring without the Needles
NeuroVigil’s iBrain: Revolutionizing Brain Monitoring without the Needles NeuroVigil, a leading neurotechnology company, launched its iBrain™ Personal Brain Monitor in four US states, selling 1.4% of its stock for over $85 million. This propelled the company’s valuation to over $6 billion, making it the highest Series B financing in history. The financing, which involved 27 […]
NeuroVigil’s iBrain: Revolutionizing Brain Monitoring without the Needles Read More »